A Randomized, Single-Blind, Placebo-Controlled, Adaptive, Ascending Dose Study to Evaluate the Effects of TRV120027 on Renal Pharmacodynamics in Patients With Heart Failure and Mild to Moderate Renal Dysfunction.
Phase of Trial: Phase I
Latest Information Update: 24 Aug 2012
At a glance
- Drugs TRV 027 (Primary)
- Indications Heart failure
- Focus Adverse reactions; Pharmacodynamics
- 24 Aug 2012 Actual initiation date (1 Aug 2011) added as reported by ClinicalTrials.gov.
- 01 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Oct 2011 New trial record